CHE Earnings & Financial Statements
Chemed Corporation
$499.82
+$1.57(+0.32%)
52
Overall
70
Value
30
Tech
57
Quality
Market Cap
$6.53B
Volume
134.46K
52W Range
$365.21 - $557.00
Target Price
$564.67
CHE earnings and financial statements: Chemed Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
CHE Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.53B | $2.43B | $2.26B | $2.13B | $2.14B |
| Cost of revenue | $1.71B | $1.58B | $1.47B | $1.37B | $1.37B |
| Operating income | $338.25M | $366.49M | $340.57M | $343.50M | $343.04M |
| EBITDA | $422.69M | $464.62M | $414.92M | $393.78M | $411.23M |
| Net income | $265.24M | $302.00M | $272.51M | $249.62M | $268.55M |
| EPS (diluted) | $18.34 | $19.89 | $17.93 | $16.53 | $16.85 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.54B | $1.67B | $1.67B | $1.44B | $1.34B |
| Total liabilities | $558.78M | $549.58M | $560.22M | $643.30M | $719.45M |
| Shareholders’ equity | $979.40M | $1.12B | $1.11B | $798.72M | $623.27M |
| Cash and equivalents | $74.52M | $178.35M | $263.96M | $74.13M | $32.90M |
| Long-term debt | $102.87M | $98.54M | $100.78M | $203.01M | $285.63M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $388.27M | $417.50M | $330.30M | $309.89M | $308.60M |
| Capital expenditure | -$58.23M | -$46.22M | -$56.85M | -$57.33M | -$57.77M |
| Free cash flow | $325.48M | $367.97M | $273.44M | $252.56M | $250.83M |
| Dividends paid | $31.70M | $27.09M | $23.50M | $22.02M | $22.02M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CHE | $499.82 | +0.3% | 134.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |